Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients present with autism-like neurobehavioral phenotypes, including social deficits and epileptic seizures [20–22]”
From Behavioral phenotyping identifies autism-like repetitive stereotypies in a Tsc2 haploinsufficient rat model (2025) · cites this paper as [21]
In the citing paper
“However, along with concerns about absent spontaneous seizure activity, the lack of repetitive behavior characterization sparks debate about the suitability of the Eker rat as an ASD model [21].”
From Behavioral phenotyping identifies autism-like repetitive stereotypies in a Tsc2 haploinsufficient rat model (2025) · cites this paper as [21]
In the citing paper
“Reportedly, Eker rats recapitulate brain abnormalities and cellular pathology present in human TSC [21, 32–34]”
From Behavioral phenotyping identifies autism-like repetitive stereotypies in a Tsc2 haploinsufficient rat model (2025) · cites this paper as [21]
In the citing paper
“The entirety of observed brain malformations, cellular aberrations, and impairments of neuroplasticity suggests cognitive deficits to be present in the Tsc2+/− Eker rat [21].”
From Behavioral phenotyping identifies autism-like repetitive stereotypies in a Tsc2 haploinsufficient rat model (2025) · cites this paper as [21]
In the citing paper
“In case of TSC, spontaneous seizure development as a hallmark manifestation cannot be recapitulated in animal models so far [21].”
From Behavioral phenotyping identifies autism-like repetitive stereotypies in a Tsc2 haploinsufficient rat model (2025) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237
Organizing the cell cortex: the role of ERM proteins
Fehon, R. G., McClatchey, A. I., & Bretscher, A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2866 · Cited by 1,044
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity
Hahn-Windgassen, A., Nogueira, V., Chen, C.-C., Skeen, J. E., Sonenberg, N., & Hay, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502876200 · Cited by 539
Meikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E., & Kwiatkowski, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5540-06.2007 · Cited by 462
Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis
Kwiatkowski, D. J. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.446 · Cited by 387
Uhlmann, E. J., Wong, M., Baldwin, R. L., Bajenaru, M. L., Onda, H., Kwiatkowski, D. J., Yamada, K., & Gutmann, D. H. (2002) · Annals of Neurology · doi:10.1002/ana.10283 · Cited by 372
Research works printed but not linked: 109
- Crino, P.B., mTOR signaling in epilepsy: insights from malformations of cortical development. Cold Spring Harb Perspect Med, 2015. 5(4):a022442. https://doi.org/10.1101/cshperspect.a022442. · DOI · Paper page
- Saxton, 2017, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 169, 361, 10.1016/j.cell.2017.03.035 · DOI · Paper page
- Dentel, 2019, Therapeutic Targeting of mTORC2 in mTORopathies, Neuron, 104, 1032, 10.1016/j.neuron.2019.11.026 · DOI
- Richardson, 1991, Pathology of tuberous sclerosis. Neuropathologic aspects, Ann N Y Acad Sci, 615, 128, 10.1111/j.1749-6632.1991.tb37755.x · DOI
- Vinters, 1999, Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes, Dev Neurosci, 21, 248, 10.1159/000017404 · DOI
- Eker, 1954, Familial renal adenomas in Wistar rats; a preliminary report, Acta Pathol Microbiol Scand, 34, 554, 10.1111/j.1699-0463.1954.tb00301.x · DOI
- Eker, 1981, Hereditary renal adenomas and adenocarcinomas in rats, Diagn Histopathol, 4, 99
- Yeung, 1997, Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis, Am J Pathol, 151, 1477
- Kutna, 2020, Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia, Neurotherapeutics, 17, 329, 10.1007/s13311-019-00812-6 · DOI · Paper page
- Waltereit, 2006, Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis, J Neurochem, 96, 407, 10.1111/j.1471-4159.2005.03538.x · DOI · Paper page
- Rennebeck, 1998, Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development, Proc Natl Acad Sci U S A, 95, 15629, 10.1073/pnas.95.26.15629 · DOI · Paper page
- Knudson, 1971, Mutation and cancer: statistical study of retinoblastoma, Proc Natl Acad Sci U S A, 68, 820, 10.1073/pnas.68.4.820 · DOI · Paper page
- Tomlinson, 2001, Two hits revisited again, J Med Genet, 38, 81, 10.1136/jmg.38.2.81 · DOI
- Afshar Saber, 2020, Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex, Mol Autism, 11, 16, 10.1186/s13229-020-0320-2 · DOI · Paper page
- Blair, 2020, New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids, Dev Dyn, 249, 46, 10.1002/dvdy.60 · DOI
- Robertson, F.L., et al., Experimental models and tools to tackle glioblastoma. Dis Model Mech, 2019. 12(9):dmm040386. https://doi.org/10.1242/dmm.040386. · DOI
- Parsa, 2000, Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy, Neurosurgery, 47, 993, 10.1097/00006123-200010000-00050 · DOI
- Workman, 2010, Guidelines for the welfare and use of animals in cancer research, Br J Cancer, 102, 1555, 10.1038/sj.bjc.6605642 · DOI · Paper page
- Simons, B.W. and C. Brayton, Challenges and Limitations of Mouse Xenograft Models of Cancer. Patient Derived Tumor Xenograft Models, ed. R. Uthamanthil and P. Tinkey. 2016, Johns Hopkins University School of Medicine, Baltimore, MD, United States: Academic Press. · DOI
- Kim, 2016, Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments, Cancer Cell Int, 16, 43, 10.1186/s12935-016-0319-0 · DOI
- Fryer, 1987, Evidence that the gene for tuberous sclerosis is on chromosome 9, Lancet, 1, 659, 10.1016/S0140-6736(87)90416-8 · DOI · Paper page
- Kandt, 1992, Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease, Nat Genet, 2, 37, 10.1038/ng0992-37 · DOI · Paper page
- Henske, 2016, Tuberous sclerosis complex, Nat Rev Dis Primers, 2, 16035, 10.1038/nrdp.2016.35 · DOI · Paper page
- Lam, 2018, Renal disease in tuberous sclerosis complex: pathogenesis and therapy, Nat Rev Nephrol, 14, 704, 10.1038/s41581-018-0059-6 · DOI
- Bongaarts, 2017, Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations, Oncotarget, 8, 95516, 10.18632/oncotarget.20764 · DOI
- Rosset, 2017, TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review, Genet Mol Biol, 40, 69, 10.1590/1678-4685-gmb-2015-0321 · DOI
- Lamb, 2000, The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho, Nat Cell Biol, 2, 281, 10.1038/35010550 · DOI · Paper page
- Haddad, 2002, The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton, J Biol Chem, 277, 44180, 10.1074/jbc.M207211200 · DOI · Paper page
- Schopel, 2017, The small GTPases Ras and Rheb studied by multidimensional NMR spectroscopy: structure and function, Biol Chem, 398, 577, 10.1515/hsz-2016-0276 · DOI
- Kleijer, 2014, Neurobiology of autism gene products: towards pathogenesis and drug targets, Psychopharmacology, 231, 1037, 10.1007/s00213-013-3403-3 · DOI · Paper page
- Kobayashi, 1997, Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog, Mamm Genome, 8, 554, 10.1007/s003359900502 · DOI
- Maheshwar, 1997, The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis, Hum Mol Genet, 6, 1991, 10.1093/hmg/6.11.1991 · DOI · Paper page
- Nussinov, 2020, The Mystery of Rap1 Suppression of Oncogenic Ras, Trends Cancer, 6, 369, 10.1016/j.trecan.2020.02.002 · DOI
- Jaskiewicz, A., B. Pajak, and A. Orzechowski, The Many Faces of Rap1 GTPase. Int J Mol Sci, 2018. 19(10):2848. https://doi.org/10.3390/ijms19102848. · DOI
- Rubinfeld, 1991, Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1, Cell, 65, 1033, 10.1016/0092-8674(91)90555-D · DOI · Paper page
- Yeung, 2004, Lessons from the Eker rat model: from cage to bedside, Curr Mol Med, 4, 799, 10.2174/1566524043359791 · DOI
- Soucek, 1997, Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase, J Biol Chem, 272, 29301, 10.1074/jbc.272.46.29301 · DOI · Paper page
- Jin, 2017, Importance of tuberin in carcinogenesis, Oncol Lett, 14, 2598, 10.3892/ol.2017.6490 · DOI
- Rosner, 2007, Cytoplasmic/nuclear localization of tuberin in different cell lines, Amino Acids, 33, 575, 10.1007/s00726-007-0541-0 · DOI
- Wienecke, 1996, Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus, Oncogene, 13, 913
- Demetriades, 2014, Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2, Cell, 156, 786, 10.1016/j.cell.2014.01.024 · DOI · Paper page
- Johnson, 2001, Hamartin and tuberin expression in human tissues, Mod Pathol, 14, 202, 10.1038/modpathol.3880286 · DOI
- Li, 2018, Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex, Sci Rep, 8, 13373, 10.1038/s41598-018-31075-4 · DOI
- Dan, 2016, Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin, J Biol Chem, 291, 22848, 10.1074/jbc.A116.205838 · DOI
- Inoki, 2002, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nat Cell Biol, 4, 648, 10.1038/ncb839 · DOI · Paper page
- Ma, 2007, Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer, Cancer Res, 67, 7106, 10.1158/0008-5472.CAN-06-4798 · DOI · Paper page
- Nie, 2010, Tsc2-Rheb signaling regulates EphA-mediated axon guidance, Nat Neurosci, 13, 163, 10.1038/nn.2477 · DOI · Paper page
- Han, 2008, Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC/mTOR signaling, Cell Signal, 20, 1084, 10.1016/j.cellsig.2008.01.020 · DOI
- Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell, 115, 577, 10.1016/S0092-8674(03)00929-2 · DOI · Paper page
- Lee, 2007, IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway, Cell, 130, 440, 10.1016/j.cell.2007.05.058 · DOI · Paper page
- Goncharova, 2002, Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM), J Biol Chem, 277, 30958, 10.1074/jbc.M202678200 · DOI · Paper page
- Cheadle, 2000, Molecular genetic advances in tuberous sclerosis, Hum Genet, 107, 97, 10.1007/s004390000348 · DOI · Paper page
- Napolioni, 2008, Genetics and molecular biology of tuberous sclerosis complex, Curr Genomics, 9, 475, 10.2174/138920208786241243 · DOI
- Osborne, 1991, Epidemiology of tuberous sclerosis, Ann N Y Acad Sci, 615, 125, 10.1111/j.1749-6632.1991.tb37754.x · DOI · Paper page
- Samueli, 2015, Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management, Wien Klin Wochenschr, 127, 619, 10.1007/s00508-015-0758-y · DOI
- Prather, 2004, Behavioral and cognitive aspects of tuberous sclerosis complex, J Child Neurol, 19, 666, 10.1177/08830738040190090601 · DOI · Paper page
- de Vries, 2018, A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND), Am J Med Genet C: Semin Med Genet, 178, 309, 10.1002/ajmg.c.31637 · DOI · Paper page
- Gipson, 2013, Potential for treatment of severe autism in tuberous sclerosis complex, World J Clin Pediatr, 2, 16, 10.5409/wjcp.v2.i3.16 · DOI
- Hunt, 1987, Psychiatric disorder among children with tuberous sclerosis, Dev Med Child Neurol, 29, 190, 10.1111/j.1469-8749.1987.tb02135.x · DOI · Paper page
- Holmes, 2007, Study, Tuberous sclerosis complex and epilepsy: recent developments and future challenges, Epilepsia, 48, 617, 10.1111/j.1528-1167.2007.01035.x · DOI · Paper page
- Nabbout, 2019, Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study, Epilepsia Open, 4, 73, 10.1002/epi4.12286 · DOI · Paper page
- Braffman, 1992, MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review, Radiology, 183, 227, 10.1148/radiology.183.1.1549677 · DOI · Paper page
- Ridler, 2004, Standardized whole brain mapping of tubers and subependymal nodules in tuberous sclerosis complex, J Child Neurol, 19, 658, 10.1177/08830738040190090501 · DOI · Paper page
- Peters, 2013, Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions, Future Neurol, 8, 583, 10.2217/fnl.13.37 · DOI
- Yamanouchi, 1997, Giant cells in cortical tubers in tuberous sclerosis showing synaptophysin-immunoreactive halos, Brain and Development, 19, 21, 10.1016/S0387-7604(96)00079-4 · DOI
- Grajkowska, 2010, Brain lesions in tuberous sclerosis complex. Review, Folia Neuropathol, 48, 139
- Fohlen, 2018, Refractory epilepsy in preschool children with tuberous sclerosis complex: Early surgical treatment and outcome, Seizure, 60, 71, 10.1016/j.seizure.2018.06.005 · DOI
- Kalantari, 2008, Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging, AJR Am J Roentgenol, 190, W304, 10.2214/AJR.07.2928 · DOI
- Yamanouchi, 1997, Evidence of abnormal differentiation in giant cells of tuberous sclerosis, Pediatr Neurol, 17, 49, 10.1016/S0887-8994(97)00036-2 · DOI
- Henske, 1997, Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors, Am J Pathol, 151, 1639
- DiMario, 2004, Brain abnormalities in tuberous sclerosis complex, J Child Neurol, 19, 650, 10.1177/08830738040190090401 · DOI · Paper page
- Goh, 2004, Subependymal giant cell tumors in tuberous sclerosis complex, Neurology, 63, 1457, 10.1212/01.WNL.0000142039.14522.1A · DOI · Paper page
- Adriaensen, 2009, Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature, Eur J Neurol, 16, 691, 10.1111/j.1468-1331.2009.02567.x · DOI · Paper page
- Cuccia, 2003, Subependymal giant cell astrocytoma in children with tuberous sclerosis, Childs Nerv Syst, 19, 232, 10.1007/s00381-002-0700-2 · doi:10.1007/s00381-002-0700-2
- Buccoliero, 2009, Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study, Neuropathology, 29, 25, 10.1111/j.1440-1789.2008.00934.x · DOI
- Hirose, 1995, Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study, Acta Neuropathol, 90, 387, 10.1007/BF00315012 · DOI
- Di Rocco, 1995, On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis, Pediatr Neurosurg, 23, 115, 10.1159/000120947 · doi:10.1159/000120947
- Kim, 2017, Subependymal Giant Cell Astrocytoma Presenting with Tumoral Bleeding: A Case Report, Brain Tumor Res Treat, 5, 37, 10.14791/btrt.2017.5.1.37 · DOI
- Ess, 2005, Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex, Neurology, 64, 1446, 10.1212/01.WNL.0000158653.81008.49 · DOI · Paper page
- Ess, 2004, Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology, Glia, 46, 28, 10.1002/glia.10324 · DOI
- Feng, 1994, Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS, Neuron, 12, 895, 10.1016/0896-6273(94)90341-7 · DOI · Paper page
- Jozwiak, 2004, Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis, J Child Neurol, 19, 102, 10.1177/08830738040190020401 · DOI
- Mizuguchi, 2000, Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma, J Neuropathol Exp Neurol, 59, 188, 10.1093/jnen/59.3.188 · DOI
- Takahashi, 2004, Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex, Epilepsia, 45, 1525, 10.1111/j.0013-9580.2004.23004.x · DOI · Paper page
- Wenzel, 2004, Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis, Acta Neuropathol, 108, 97, 10.1007/s00401-004-0865-8 · DOI
- Wippold, 2006, A. Perry, and J. Lennerz, Neuropathology for the neuroradiologist: Rosenthal fibers, AJNR Am J Neuroradiol, 27, 958
- Curatolo, 1991, Neuropsychiatric aspects of tuberous sclerosis, Ann N Y Acad Sci, 615, 8, 10.1111/j.1749-6632.1991.tb37743.x · DOI · Paper page
- Almobarak, 2018, Tuberous Sclerosis Complex: Clinical Spectrum and Epilepsy: A Retrospective Chart Review Study, Transl Neurosci, 9, 154, 10.1515/tnsci-2018-0023 · DOI
- Tschuluun, 2007, Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability, Epilepsy Res, 73, 53, 10.1016/j.eplepsyres.2006.08.003 · DOI
- Cooper, 2012, The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis, Neurochem Res, 37, 2355, 10.1007/s11064-012-0803-4 · DOI · Paper page
- Ito, 2001, Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain, Stroke, 32, 1208, 10.1161/01.STR.32.5.1208 · DOI · Paper page
- Kirschstein, 2012, Synaptic plasticity and learning in animal models of tuberous sclerosis complex, Neural Plast, 2012, 279834, 10.1155/2012/279834 · DOI
- Lee, 2015, Autism spectrum disorder and epilepsy: Disorders with a shared biology, Epilepsy Behav, 47, 191, 10.1016/j.yebeh.2015.03.017 · DOI · Paper page
- Switon, 2016, Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches, IUBMB Life, 68, 955, 10.1002/iub.1579 · DOI
- Switon, 2017, Molecular neurobiology of mTOR, Neuroscience, 341, 112, 10.1016/j.neuroscience.2016.11.017 · DOI · Paper page
- Goorden, 2007, Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures, Ann Neurol, 62, 648, 10.1002/ana.21317 · DOI · Paper page
- Ovsepian, 2017, Ambient Glutamate Promotes Paroxysmal Hyperactivity in Cortical Pyramidal Neurons at Amyloid Plaques via Presynaptic mGluR1 Receptors, Cereb Cortex, 27, 4733
- Ovsepian, 2016, Neuronal activity and amyloid plaque pathology: an update, J Alzheimers Dis, 49, 13, 10.3233/JAD-150544 · DOI · Paper page
- Ovsepian, 2019, Amyloid Plaques of Alzheimer's Disease as Hotspots of Glutamatergic Activity, Neuroscientist, 25, 288, 10.1177/1073858418791128 · DOI
- von der Brelie, 2006, Impaired synaptic plasticity in a rat model of tuberous sclerosis, Eur J Neurosci, 23, 686, 10.1111/j.1460-9568.2006.04594.x · DOI · Paper page
- Chu-Shore, C., et al., The natural history of epilepsy in tuberous sclerosis complex. , ed. Epilepsia. 2010, John Wiley & Sons, Ltd; 2010;51(7):1236–1241. · DOI · Paper page
- Vignoli, A., et al., Epilepsy in TSC: Certain etiology does not mean certain prognosis. Epilepsia. . 2013: John Wiley & Sons, Ltd. · DOI
- Kobayashi, 2001, A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice, Proc Natl Acad Sci U S A, 98, 8762, 10.1073/pnas.151033798 · DOI · Paper page
- Zeng, 2011, Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex, Hum Mol Genet, 20, 445, 10.1093/hmg/ddq491 · DOI · Paper page
- Onda, 1999, Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background, J Clin Invest, 104, 687, 10.1172/JCI7319 · DOI · Paper page
- Way, 2009, Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse, Hum Mol Genet, 18, 1252, 10.1093/hmg/ddp025 · DOI · Paper page
- Crowell, B., et al., Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123). eNeuro, 2015. 2(6):ENEURO.0046-15.2015. https://doi.org/10.1523/ENEURO.0046-15.2015. · DOI
- Steele, 1999, Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5, Hippocampus, 9, 118, 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8 · DOI · Paper page
- Waltereit, 2011, Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats, Behav Genet, 41, 364, 10.1007/s10519-010-9399-0 · DOI · Paper page
Cited by
Ramme, A., Zachow, M., Habelt, B., Vojtechova, I., Petrasek, T., Waltereit, R., & Bernhardt, N. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00284-z · Cited by 1
Metadata
- Authors
- Kútna, V., O'Leary, V. B., Newman, E., Hoschl, C., & Ovsepian, S. V.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 18
- Issue
- 2
- Pages
- 845-858
- ISSN
- 1878-7479
- Cited by
- 11
- References
- 13
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 869 d)
- Funders
- NUP (LO1611)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes. https://app.cochat.ai/papers/10.1007/s13311-020-01000-7
- The paper
- Kútna, V., O'Leary, V. B., Newman, E., Hoschl, C., & Ovsepian, S. V. (2021). Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes. Neurotherapeutics. https://doi.org/10.1007/s13311-020-01000-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.